Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Strategy
MSTR
US Stock MarketDetailed Quotes
PHIO Phio Pharmaceuticals
- 1.2900
- -0.0100-0.77%
Close Mar 10 16:00 ET
- 1.3500
- +0.0600+4.65%
Pre 09:08 ET
6.16MMarket Cap-0.13P/E (TTM)
1.3300High1.2700Low57.19KVolume1.2900Open1.3000Pre Close73.88KTurnover1.20%Turnover RatioLossP/E (Static)4.78MShares9.990052wk High1.25P/B6.16MFloat Cap1.220152wk Low--Dividend TTM4.77MShs Float3118.4994Historical High--Div YieldTTM4.62%Amplitude1.2201Historical Low1.2910Avg Price1Lot Size
Phio Pharmaceuticals Stock Forum
American Academy of Dermatology Awards Podium Presentation to Phio Pharmaceutical's Clinical Research at 2025 Annual Meeting
Can Phio's INTASYL Technology Transform Skin Cancer Treatment? Trial Reaches Key Milestone
Benzinga· just
Phio Pharmaceuticals Announces Completion of Enrollment in Third Safety Cohort in PH-762 Phase 1b Dose-Escalation Study
Wednesday, 5th March at 7:45 am
Marlborough, Massachusetts--(Newsfile Corp. - March 5, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics that use its INTASYL® siRNA gene silencing technology designed to make the body's immune cells more effective in killing cancer cells. Phio ...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; F...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, I...
Renmark Financial Communications Inc.
Hopefully things could change, otherwise will have to wait until the next earnings or results from the next phase of clinical trial. Presentation would be on 5th February 3am SGT.
No comment yet